Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion

MT Newswires Live
Dec 30, 2025

Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.

The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.

The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.

The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.

The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.

Net proceeds will be used primarily for research and development activities and to commercialize the company's products.

Morgan Stanley Asia, GF Securities (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10